Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Fang Cheng

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Gynecologic Oncology|July 15, 2014
Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group studyKeng-Fu Hsu, Hung-Hsueh Chou, Chia-Yen Huang, et al.
Analytical Biochemistry|March 31, 2009
Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysisChia-Cheng Hung, Shin-Yu Lin, Chien-Nan Lee, et al.
Journal of Gynecologic Oncology|July 20, 2018
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort studyHung Chun Fu, Jen Ruei Chen, Min Yu Chen, et al.
Annals of Human Genetics|October 21, 2009
Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndromeChia-Cheng Hung, Shin-Yu Lin, Chien-Nan Lee, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 29, 2015
Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factorsI-Lun Shih, Ruoh-Fang Yen, Chi-An Chen, et al.
The Lancet. Oncology|December 1, 2023
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialBradley J Monk, Takafumi Toita, Xiaohua Wu, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Gynecologic Oncology|July 15, 2014
Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group studyKeng-Fu Hsu, Hung-Hsueh Chou, Chia-Yen Huang, et al.
Analytical Biochemistry|March 31, 2009
Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysisChia-Cheng Hung, Shin-Yu Lin, Chien-Nan Lee, et al.
Journal of Gynecologic Oncology|July 20, 2018
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort studyHung Chun Fu, Jen Ruei Chen, Min Yu Chen, et al.
Annals of Human Genetics|October 21, 2009
Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndromeChia-Cheng Hung, Shin-Yu Lin, Chien-Nan Lee, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 29, 2015
Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factorsI-Lun Shih, Ruoh-Fang Yen, Chi-An Chen, et al.
The Lancet. Oncology|December 1, 2023
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialBradley J Monk, Takafumi Toita, Xiaohua Wu, et al.
Pageof 16